Skip to main content
Log in

Hormone replacement therapy and its influence on AT-III activity in climacteric women

  • Research Quickie
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abbreviations

E2 :

Östradiol

FSH:

Follicle stimulating hormone

TTS:

Transdermal therapeutic system

References

  1. Conrad J, Cazenave B, Samana M, Horeliou MH, Zorn JR, Neak C (1980) AT-III content and antithrombin activity in oestrogen-progesteron and progestogen only treated women. Thromb Res 18:675–681

    Google Scholar 

  2. Hesse R, Trischler W, Castelfranchi G, Bablok W (1981) Antithrombin III. Referenzwerte mit einem chromogenen, Substrat (Chromozym TH). Blut 42:227–234

    Google Scholar 

  3. Toy JL (1978) The compactive effects of a synthetic and a “normal” oestrogen on the haemostatic mechanism in patients with primary amenorrhoea. Brit J Obstet Gynaecol 85:359–362

    Google Scholar 

  4. Völcker W, Hesch RD, Schneider HPG (1985) Gedanken zur Langzeit-Östrogen-Substitution. Müssen Gynäkologen umdenken? Geburtsh Frauenheilk 45:326–332

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enzelsberger, H., Heytmanek, G., Kurz, C. et al. Hormone replacement therapy and its influence on AT-III activity in climacteric women. Klin Wochenschr 69, 232 (1991). https://doi.org/10.1007/BF01646949

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01646949

Keywords

Navigation